Maravai LifeSciences (MRVI)
(Delayed Data from NSDQ)
$7.70 USD
+0.12 (1.58%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
MRVI 7.70 +0.12(1.58%)
Will MRVI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MRVI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRVI
Are Options Traders Betting on a Big Move in Maravai LifeSciences (MRVI) Stock?
Zynex Inc. (ZYXI) Q3 Earnings Match Estimates
MRVI: What are Zacks experts saying now?
Zacks Private Portfolio Services
PetIQ (PETQ) Moves 5.7% Higher: Will This Strength Last?
Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates
ZimVie Inc. (ZIMV) Stock Jumps 20.6%: Will It Continue to Soar?
Other News for MRVI
Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI)
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
HROW, HCAT and EGRX are among after hour movers
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Craig-Hallum bullish on Maravai Lifesciences, initiates with a Buy